Yingyan (Celine) Lin is an Associate Professor in the School of Computer Science at Georgia Institute of Technology, leading the Efficient and Intelligent Computing (EIC) Lab. Her work focuses on cross-layer innovations in machine learning systems, from algorithms to chip design, aiming to advance green AI and ubiquitous machine learning. She holds a Ph.D. in Electrical and Computer Engineering from the University of Illinois at Urbana-Champaign (2017). Research interests include efficient machine learning, neural rendering (e.g., NeRF), hardware-software co-design for AI acceleration, and graph neural networks. Her lab has pioneered projects like RTML and 3DML, funded by NSF, NIH, DARPA, and industry partners (Qualcomm, Intel, Meta). Awards: NSF CAREER Award (2021), ACM SIGDA Outstanding Young Faculty (2022), Meta Faculty Research Award (2022) Grants: Multi-university projects funded by NSF, NIH, DARPA, SRC, ONR, and industry Recognition: First-place wins at DAC 2022 and TinyML Design Contest 2022, IEEE Micro Top Pick 2023 Her research bridges algorithmic innovation with hardware implementation, emphasizing energy efficiency and real-time performance for applications in AR/VR, computer vision, and neuro-symbolic AI systems.
Prof. Paul Stupple is a Professor of Medicinal Chemistry at Monash University, Australia, with over 20 years' experience in pharmaceutical industry and academia. He holds leadership roles at Canthera Discovery and manages the Australian Translational Medicinal Chemistry Facility. His expertise lies in small molecule drug discovery, particularly targeting cancer therapies and epigenetic regulators. Affiliations: Monash University, Faculty of Pharmacy and Pharmaceutical Sciences Canthera Discovery (Director, Medicinal Chemistry) Education: BA and DPhil in Chemistry from the University of Oxford (1992–1999). Early career at Pfizer as a medicinal chemistry leader, delivering 6 clinical candidates. Key contributions include: Licensing deals with Merck (2016) and Pfizer (2018) for preclinical projects Leading the Cancer Therapeutics CRC's medicinal chemistry program Research Interests: Small molecule drug discovery focused on histone acetyltransferase inhibitors, cancer therapeutics, and epigenetic modulation. Notable projects include development of KAT6A/B inhibitors for ER+ breast cancer and STING agonists for immunotherapy. Grants/Projects: Principal Investigator for major initiatives like MedChem Australia (2023–2028) and drug target identification platforms. Collaborates widely with institutions like WEHI and University of Sydney. Over 28 peer-reviewed publications spanning 1997–2025. Labs/Teams: Oversees the Australian Translational Medicinal Chemistry Facility, a key resource for drug discovery in Australia.
Jenny Ouyang is an Associate Professor in the Department of Biology at the University of Nevada, Reno , where she also serves as Director of the Ecology, Evolution and Conservation Biology graduate program. She earned her B.S. and B.A. from the University of California, Irvine (2007), followed by M.A. and Ph.D. in Ecology and Evolutionary Biology from Princeton University (2009, 2012). Her research focuses on the ecology and evolution of physiological systems , particularly how hormonally regulated traits enable organismal adaptation to environmental changes like urbanization , light pollution , and endocrine stress responses . Education: Ph.D., Ecology and Evolutionary Biology, Princeton University (2012) M.A., Ecology and Evolutionary Biology, Princeton University (2009) B.S., Biology, University of California, Irvine (2007) B.A., French, University of California, Irvine (2007) Her work integrates neuroendocrine mechanisms with ecological contexts to understand phenotypic flexibility and epigenetic adaptation in birds. Recent projects examine how artificial light at night disrupts circadian rhythms, hormonal profiles, and parental behaviors across urban-rural gradients. She has secured major grants including the NSF CAREER award (2022) for studying urbanization and NIH COBRE funding (2017) as part of a neuroscience team. Key collaborations include Dr. Maria Echeverry at Universidad Pontificia Javeriana in Colombia through her 2023 Fulbright award . The Ouyang Lab combines natural and laboratory experiments to investigate stress physiology, with recent papers analyzing glucocorticoid responses to urbanization, gene expression patterns under light pollution, and epigenetic reorganization in response to environmental stressors. Her publications span top journals like Proceedings of the Royal Society B , Biology Letters , and Ecology Applications , where her 2022 paper on lead pollution and reproduction was highlighted by ESA and Swedish Radio. Scientific Awards & Recognition: US Fulbright Scholars Award (2023) NSF CAREER grant (2022) NIH COBRE grant (2017) as team member Advising students like Valentina Alaasam (NSF GRFP awardee) and Ivan Celso Carvalho Provinciato (Dean's Merit Fellowship)
Dr. Anna Hopkins is a Senior Lecturer in conservation biology and molecular ecology at Edith Cowan University's School of Science. She is the Course Coordinator for postgraduate Environmental Science programs and has held academic positions since 2016. Her research focuses on soil microbial ecology, forest pathogens, eDNA applications, and climate change impacts. She has taught courses including Plant Pathology, Genetics, and Soil Processes. Education: PhD (University of Tasmania, 2007), Diploma of Modern Languages (UWA, 2002), BSc (Hons) (UWA, 2002) Her research interests include mycorrhizal-plant interactions, soil fungal responses to disturbances, and regenerative agriculture. Notable awards include the 2010 New Zealand Zonta Women in Science Award and the 2017 ECU Athena Swan Award. Recent articles highlight her work on soil microbial dynamics, invasive species management, and eDNA applications in ecology. She has led projects funded by organizations like the Australian Coal Association and WWF Australia, focusing on biodiversity restoration and ecosystem health. Awards: Multiple international and teaching awards, including recognition for poster presentations and research excellence. Advising & Grants: Supervises 5 PhD/MSc students and leads grants totaling over $1M in projects like eDNA tracking and Gilbert’s Potoroo conservation. Professional roles include Deputy Coordinator of the IUFRO Working Party on Forest Nurseries and Vice President of the Australasian Mycological Society.
Professor Omar Matar is a Professor of Fluid Mechanics and RAEng/PETRONAS Research Chair in Multiphase Fluid Dynamics at the Department of Chemical Engineering, Imperial College London. He leads the Matar Fluids Group, focusing on interfacial fluid mechanics, multiphase flows, computational fluid dynamics (CFD), and applications in energy, manufacturing, and nanotechnology. His roles include Head of Department of Chemical Engineering, Director of the PETRONAS Centre for Engineering of Multiphase Systems (PETCEMS), and Editor-in-Chief of the Journal of Engineering Mathematics. Education: PhD in Chemical Engineering, Princeton University (1993) MEng Chemical Engineering, Imperial College London (1989) Research Interests: Interfacial fluid mechanics, multiphase flows, CFD, and machine learning 2D materials exfoliation and scale-up, immersive technologies (AR/VR) Applications in energy systems, nanotechnology, and personalized education Awards: Fellow of the Royal Academy of Engineering (2020) Recipient of the Imperial College President’s Medal (2020) EPSRC Programme Grant Principal Investigator (MEMPHIS, PREMIERE) Grants & Projects: MEMPHIS: £5M EPSRC-funded Programme Grant (2012–2017) PREMIERE: EPSRC Programme Grant (2019–present) PETCEMS: PETRONAS-funded Centre for Multiphase Systems Engineering Labs & Collaborations: Leads the Matar Fluids Group, collaborating with institutions like UCL, University of Edinburgh, and industry partners such as BP and First Light Fusion. Active in developing high-performance CFD codes (e.g., BLUE) and machine learning-driven models for multiphase systems.
David S. Eisenberg is a Professor of Chemistry and Biochemistry and Biological Chemistry at the University of California, Los Angeles, where he also serves as Director of the UCLA-DOE Institute for Genomics and Proteomics and as an HHMI Investigator. His research focuses on protein interactions, particularly the structural basis for conversion of normal proteins to the amyloid state and conversion of prions to the infectious state. Dr. Eisenberg earned his undergraduate degree in biochemical sciences from Harvard College and his D.Phil. degree in theoretical chemistry from Oxford University on a Rhodes Scholarship. His postdoctoral research was on ice and water with Walter Kauzmann at Princeton and in protein crystallography with Richard Dickerson. He joined the UCLA faculty after his postdoctoral studies. Dr. Eisenberg and his research group focus on protein interactions in amyloid and prion diseases. These diseases involve protein aggregation where normal functional proteins convert to abnormal aggregated forms. Systemic amyloid diseases like dialysis-related amyloidosis result from fiber accumulation until organ failure, while neurodegenerative diseases like Alzheimer's, Parkinson's, ALS, and prion conditions appear to be caused by smaller oligomers. In 2005, his team determined the atomic-level structure for the amyloid fiber spine, revealing a 'steric zipper' of two parallel beta sheets packed across a dry interface. Since then, they've determined approximately 90 amyloid spines from 15 disease-related proteins. In 2010, they identified the structure of a toxic amyloid-related oligomer consisting of six anti-parallel beta strands forming a cylindrical barrel. His recent publications demonstrate continued innovation in amyloid research, with focus areas including structural prediction of amyloid formation, mechanisms of tau fibril disassembly in Alzheimer's disease, cryo-EM analysis of amyloid polymorphism, and structure-based design of inhibitors for amyloid toxicity. His work integrates computational, structural, and biochemical approaches to understand protein aggregation across multiple disease contexts. Dr. Eisenberg has received numerous prestigious awards and honors: National Academy of Sciences Member American Philosophical Society Member Institute of Medicine Member Howard Hughes Medical Institute Investigator Biophysical Society Emily M. Gray Award Harvard Westheimer Medal UCLA Seaborg Medal Technion - Israel Institute of Technology Harvey Prize in Human Health As Director of the UCLA-DOE Institute for Genomics and Proteomics and an HHMI Investigator, Dr. Eisenberg leads significant research initiatives in protein structure and aggregation. His laboratory combines X-ray crystallography, bioinformatics, and biochemical techniques to investigate protein interactions, with particular emphasis on amyloid-forming proteins and their role in disease. The Eisenberg Lab, located in Boyer Hall at UCLA, maintains an active research program investigating the structural basis of protein aggregation. The lab continues to build on its landmark discoveries of amyloid structures while exploring new frontiers in understanding protein misfolding diseases and developing potential therapeutic interventions.
Michele Klingbeil is a Professor in the Department of Microbiology at the University of Massachusetts Amherst, where she leads the Klingbeil DNA Replication Laboratory. She received her PhD in Cell and Molecular Biology from the University of Toledo in 1996 and previously worked at Johns Hopkins School of Medicine before moving to UMass in July 2007. Her educational background includes: PhD in Cell and Molecular Biology, University of Toledo, 1996 Dr. Klingbeil's research focuses on the unique biology of trypanosomatid parasites, particularly Trypanosoma brucei , the causative agent of African sleeping sickness. Her laboratory investigates two main areas: (1) replication of the unusual mitochondrial DNA network called kinetoplast DNA (kDNA), and (2) nuclear DNA replication initiation. Her work on kDNA is particularly significant as this structure is essential for parasite survival but has no counterpart in mammalian hosts, making it an attractive drug target. She employs a combination of reverse genetics (RNAi), cell biology, and biochemistry to understand the replication and repair mechanisms of kDNA, with a special focus on a family of four DNA polymerases related to bacterial Pol I. Dr. Klingbeil's recent publications reveal her laboratory's deep investigation into mitochondrial DNA polymerases in trypanosomatids, with discoveries showing multiple polymerases having specialized functions in kDNA replication and repair. Her research has established that several of these polymerases are essential for parasite viability, opening new avenues for drug development. She has also made significant contributions to understanding the simplified Origin Recognition Complex in trypanosomatids compared to other eukaryotes. Dr. Klingbeil has received the Thomas G. Lessie Distinguished Lectureship Award for her impact on teaching at the graduate level. Her research is funded by the National Institutes of Health, U.S. Department of Agriculture, the Joeph P. Healey Endowment, and the University of Massachusetts Amherst. She has mentored numerous graduate and undergraduate students, including current PhD candidates Dave Bruhn, Jeniffer Concepción, and Juemin Luo, as well as visiting scholar Eva Vidal Rico. Her former students have gone on to positions at institutions including Dana Farber/Broad Institute, Regis College, and Flagship Ventures. The laboratory regularly participates in scientific conferences including the Molecular Parasitology Meeting at Woods Hole and the Kinetoplastid Molecular Cell Biology conference. Dr. Klingbeil teaches several courses including Parasitology (MICRO 590S), Parasitology Lab (MICRO 590L), Molecular Mechanisms of Pathogenesis (MICRO 797P), Advanced Cell Biology (MCB 641), and Writing in Microbiology (MICRO 360). Her laboratory organizes regular social events including pumpkin carving parties and outings to Six Flags New England and Mt. Sugarloaf.
Sachdev Sidhu is a Research Professor and Entrepreneur in Residence at the University of Waterloo. His research focuses on synthetic antibodies, protein engineering, and biotechnological applications. He leads efforts in developing novel therapeutic antibodies, engineered protein systems, and molecular tools for biomedical research. His work spans cancer therapy, viral infection countermeasures, and regenerative medicine. Sidhu is also involved in translational research, bridging academic discoveries with commercial applications through entrepreneurial ventures. Key research interests include synthetic antibody libraries, CAR T-cell engineering, ubiquitin-based therapeutics, and phage display technologies. He has contributed to advancements in targeted therapies for glioblastoma, leukemia, and ocular diseases. His team develops innovative methods for protein design, such as engineered ubiquitin variants and modular antibody architectures. Publications highlight breakthroughs in antibody-based treatments, including synNotch CAR T cells for glioblastoma and neutralizing antibodies against SARS-CoV-2. His work integrates structural biology, molecular biology, and computational approaches to address complex biomedical challenges. Sidhu collaborates with industry partners to advance technologies into clinical and commercial settings.
Dr. Manisha Kulkarni is a Professor at the School of Epidemiology and Public Health, University of Ottawa, where she holds the University Research Chair in Climate Change and Emerging Diseases. She is also the Director of the INSIGHT (Interdisciplinary Spatial Informatics for Global Health) research lab and serves as Scientific Director of the Canadian Lyme Disease Research Network (TickNet Canada). Her work spans global public health, with a focus on vector-borne and zoonotic diseases. PhD in Medical Entomology, McGill University (2006) BSc in Environmental Biology, McGill University (2001) Dr. Kulkarni's research centers on the socio-ecological determinants of infectious disease emergence, particularly malaria, Lyme disease, and West Nile virus. She applies population surveys, entomological field sampling, molecular diagnostics, and GIS to study spatio-temporal patterns and the impacts of climate change and landscape transformation on disease transmission. Her work emphasizes One Health approaches and capacity building in low-resource settings. Her recent research trends show a strong focus on geospatial modeling of vector-borne diseases, climate change adaptation, urban tick surveillance, and international collaborations in Tanzania, Benin, and Latin America. She leads interdisciplinary projects integrating drone mapping, citizen science (e.g., eTick.ca), and community participation to identify disease risk factors. Scientific awards and recognitions include: University Research Chair in Climate Change and Emerging Diseases Ontario Early Researcher Award Faculty of Medicine Award for Leadership in Global Health (2023) Researcher of the Year, Faculty of Medicine (2019) Member, College of New Scholars, Royal Society of Canada NSERC Discovery Grant and CIHR funding Dr. Kulkarni has successfully advised multiple PhD and Master’s students and leads major funded projects supported by CIHR, PHAC, CFI, IDRC, and NSERC. She has held leadership roles as Associate Dean of Global Health (2021–2024) and currently serves on the CIHR Institute of Infection and Immunity advisory board. Her lab, INSIGHT, fosters an interdisciplinary training environment combining field, lab, and analytical methods for global health research. Key research teams and collaborations include: INSIGHT Lab, University of Ottawa Pan-African Malaria Vector Research Consortium (PAMVERC) Canadian Lyme Disease Research Network (TickNet Canada) London School of Hygiene & Tropical Medicine (LSHTM) National Microbiology Lab, PHAC Centre de Recherche Entomologique de Cotonou (CREC), Benin
Ron Dror is the Cheriton Family Professor of Computer Science at the Stanford Artificial Intelligence Lab , with courtesy appointments in Structural Biology and Molecular & Cellular Physiology . He also holds affiliations with Bio-X, the Institute for Human-Centered Artificial Intelligence (HAI), the Institute for Computational and Mathematical Engineering (ICME), Sarafan ChEM-H, and the Wu Tsai Neurosciences Institute. Education: PhD in Electrical Engineering and Computer Science, MIT MPhil in Biological Sciences, University of Cambridge (Churchill Scholar) BS in Mathematics and Electrical & Computer Engineering, Rice University (summa cum laude) Ron leads a multidisciplinary research group that combines molecular simulation and machine learning to study biomolecular structure, dynamics, and function. His work focuses on developing computational methods to accelerate drug discovery by predicting molecular interactions and designing more effective therapeutics. Current projects include the PENSA software library for analyzing biomolecular ensembles and FRAME framework for structure-based ligand design. His research has produced groundbreaking work on G-protein-coupled receptors (GPCRs) , RNA structure prediction , and mitochondrial transport mechanisms . Key publications highlight applications of geometric deep learning and molecular dynamics simulations in structural biology. Scientific Awards: Cheriton Family Professorship (2023) Two Gordon Bell Prizes (2014, 2009) Best Paper Awards at NeurIPS (2021), IPDPS (2013), SC11 (2011), SC09 (2009), SC06 (2006) Science Magazine Top 10 Breakthrough (2010) Fulbright Scholarship , NSF Fellowship , DoD Fellowship , Whitaker Foundation Fellowship Ron has advised numerous doctoral and master’s students including EJ Fine , Masha Karelina , and Briana Sobecks . His lab collaborates with experimentalists across academia and industry, applying computational methods to diverse biomedical problems such as RNA structure prediction , GPCR signaling , and mitochondrial metabolism .
Katy D. Heath is a Professor of Plant Biology and Affiliate Professor in Microbiology at the University of Illinois Urbana-Champaign (UIUC). She leads the Plant Biology department and is affiliated with the Carl R. Woese Institute for Genomic Biology. Her research focuses on the evolution of mutualisms, particularly plant-microbe interactions such as legume-rhizobium symbiosis, emphasizing genetic and ecological factors influencing symbiotic stability and adaptation. She investigates how environmental pressures (e.g., global change) shape mutualistic relationships and microbial community dynamics. Education: B.S. (2000) and Ph.D. (2007) from the University of Illinois and University of Minnesota, respectively, followed by postdoctoral work at the University of Toronto (2007–2009). Research Interests: Symbiosis evolution, microbial genetics, plasmid transmission dynamics, and the impacts of agricultural practices on rhizobia populations. She studies diverse systems, including Medicago-Sinorhizobium, soybean-Bradyrhizobium, and invasive legume-rhizobium interactions. Recent publications (2020–2025) highlight studies on endophyte impacts on soybean yield, rhizobia diversity under conventional farming, and genomic analyses of symbiotic coevolution. Her work integrates molecular biology, quantitative genetics, and ecology. Grants & Collaborations: Lead PI on a $12.5M NSF Biology Integration Institute (Genomics and Eco-evolution of Multi-scale Symbiosis). Her team includes collaborations with institutions like Indiana University and the University of Chicago. Labs & Teams: Heath Lab focuses on symbiosis research, with active projects on microbiome dynamics, plasmid-host coevolution, and community outreach (e.g., Boys and Girls Club collaborations). Recent lab highlights include student graduations (e.g., Ivan Sosa Marquez, Chase) and awards like the John R. Laughnan Award in Plant Biology.
Pim de Vink is a doctoral researcher at Eindhoven University of Technology , affiliated with the Biomedical Engineering department and Chemical Biology group. Supervised by dr. L.-G. Milroy and prof. L. Brunsveld , his work bridges supramolecular chemistry and chemical biology , focusing on host/guest chemistry for protein complex modulation. Education: B.Sc. in Chemistry (2014) from University of Amsterdam M.Sc. in Biomedical Engineering (2016) from TU/e Internship at Max Planck Institute for Molecular Physiology (2016) on gold-catalyzed synthesis Research Themes: His research develops switchable cucurbituril-based systems for light-controlled enzyme activation and artificial signaling networks. Key areas include protein-protein interaction stabilization , thermodynamic modeling , and allosteric nuclear receptor modulation . Publication Trends: Across JACS , Chemical Science , and RSC Chemical Biology , his work from 2017–2023 emphasizes supramolecular tools for biochemical applications. Notable contributions include 100-fold affinity enhancement of 14-3-3 ligands and UV-responsive cucurbituril release mechanisms . Grants: Funded by Netherlands Organization for Scientific Research (NWO) through Gravity program 024.001.035 and VICI grant 016.150.366.
Raphael Franzini serves as Associate Professor of Medicinal Chemistry at the University of Utah, actively contributing to the Biological Chemistry PhD Program. His research pioneers innovative chemical approaches for therapeutic development, with dual focus on DNA-encoded library technologies and bioorthogonal drug delivery systems. His educational foundation includes an M.S. from the Swiss Federal Institute of Technology (Lausanne) and a Ph.D. from Stanford University. This training underpins his group's multidisciplinary methodology combining organic synthesis, bioconjugation, computational modeling, and advanced imaging techniques. Dr. Franzini's research program centers on two transformative areas: First, advancing DNA-encoded library screening through computational integration to identify leads for challenging targets like Tankyrase and Sirtuin 6, with recent work addressing false negatives in machine learning prediction. Second, developing novel bioorthogonal release chemistry using isonitrile-tetrazine reactions for spatiotemporally controlled drug activation, validated in zebrafish models. His group emphasizes both technological innovation and therapeutic translation, with chemistry designed to minimize off-target effects in solid tumors. Analysis of his 15 most recent publications reveals escalating integration of computational methods with experimental library screening, alongside refinement of bioorthogonal release kinetics. The work spans chemical biology, medicinal chemistry, and pharmaceutical sciences, with growing emphasis on machine learning for library data interpretation and in vivo validation of drug-release systems. Dr. Franzini maintains an active research laboratory that provides comprehensive training in cutting-edge drug discovery methodologies. His group culture prioritizes both scientific innovation and researcher development, with projects spanning from fundamental reaction kinetics to therapeutic applications. The lab's infrastructure supports organic synthesis, molecular imaging, and computational analysis for advancing precision therapeutics.
Scott Hopkins is a Professor in the Department of Chemistry at the University of Waterloo, specializing in Physical Chemistry. His research integrates machine learning with experimental techniques to study ion mobility, mass spectrometry, and spectroscopic analysis. He directs the Hopkins Laboratory, focusing on computational predictions of chemical behaviors and molecular interactions. His work addresses fundamental questions in gas-phase chemistry, cluster formation, and analytical method development. Research interests span physical chemistry, computational modeling, and analytical instrumentation, with a strong emphasis on developing predictive tools for complex chemical systems. Recent investigations explore ion-solvent dynamics, fragmentation mechanisms, and machine-learning applications for spectral interpretation.
George Perry is a Professor of Anthropology at Pennsylvania State University, with research intersections in Biology, Evolutionary Medicine, and Genomics. He is affiliated with the Huck Institutes' Center for Infectious Disease Dynamics, Ecology, Molecular Cellular and Integrative Biosciences, and Bioinformatics and Genomics programs. Perry directs the Anthropological Genomics Lab , focusing on paleogenomics and evolutionary adaptation. Research areas: anthropological genomics, parasite evolution, human body size transitions, and evolutionary medicine Key collaborations: international teams in Madagascar, Europe, and Africa Leadership: Bioinformatics and Genomics Chair (2019–2023) His 2025–2022 publications span evolutionary responses to invasive species, human migration health impacts, chemosensory gene adaptation, and primate genomic diversity. Notable methodological contributions include ancient DNA recovery and comparative paleogenomics. Perry advises graduate students like Vanessa Garcia and Annette Mercedes, with grants including NIH support for Cuban health disparity studies. Scientific leadership includes tenure-line promotions (2023) and NASA Space Grant collaborations.
